Chondroprotective efficiencies of intra-articular treatment of glucosamine sulfate and hyaluronic acid
Objectives: The main purpose of this study was to determine a comparison between the chondroprotective efficacy of intra-articularadministrations of glucosamine sulphate (GS) and hyaluronic acid (HA) in the experimental knee osteoarthritis model in rats.Materials and Methods: Forty-five rats were assigned to the following three groups: GS group (Group 1), HA group (Group 2), controlgroup (Group 3). The knee joints of the rats were seen macroscopically and the anterior cruciate ligaments were resected. Two weeksafter surgery, an intra-articular injection was applied to each group for three weeks with 1 week interval. In the osteoarthritic rat kneejoints, the histopathological effects of tissue regeneration of GS and HA applications were compared with the control group.Results: The total Mankin Scale was 2.64±2.56, 3.58±3.9, 8.12±2.80 for the GS group, HA group and control group respectively.According to these results, the GS and HA were superior to the control group. The values of the total Mankin scale, cartilage structure,cellular abnormality, matrix staining and tidemark integrity of the GS group were lower than the values of the HA group but thisdifference was not statistically significant.Conclusion: According to the results of this study, intra-articular administration of GS for the management of osteoarthritis may bebeneficial for patients with knee osteoarthritis.
___
- [1] Nelson AE, Allen KD, Golightly YM, Goode AP, Jordan JM.
A systematic review of recommendations and guidelines for
the management of osteoarthritis: The
chronic osteoarthritis management initiative of the U.S. bone
and joint initiative. Semin Arthritis Rheum 2014 ;43:701-12.
doi: 10.1016/j.semarthrit.2013.11.012.
- [2] Bannuru R R, Vaysbrot E E, Sullivan M C, McAlindon T
E. Relative efficacy of hyaluronic acid in comparison with
NSAIDs for knee osteoarthritis: a systematic review and metaanalysis.
Semin Arthritis Rheum 2014;43:593-9. doi:10.1016/j.
semarthrit.2013.10.002.
- [3] Sen C, Güneş T, Saygi B, Erdem M, Köseoğlu R D, Kilic N. The
chondroprotective effect of intra-articular hyaluronic acid at
early stages of osteoarthritis: An experimental study in rabbits.
Acta Orthop Traumatol Turc 2004;38:348-52.
- [4] Özkan ÜF, Özkan K, Ramadan S, Güven Z. Chondroprotective
effect of N-acetylglucosamine and hyaluronate in early stages
of osteoarthritis an experimental study in rabbits. Bulletin of
the NYU Hospital for Joint Diseases 2009; 67:352-7.
- [5] Orak M. M, Ak D, Midi A, et al. Comparison of the effects
of chronic intra-articular administration of tenoxicam,
diclofenac, and methylprednisolone in healthy rats. Acta
Orthop Traumatol Turc 2015;49:438-46. doi: 10.3944/
AOTT.2015.14.0312.
- [6] Herrero-Beaumont G, Rovati LC, Castañeda S, Alvarez-
Soria MA, Largo R. The reverse glucosamine sulfate
pathway: application in knee osteoarthritis. Expert
Opin Pharmacother. 2007 Feb;8(2):215-25. DOI:
10.1517/14656566.8.2.215
- [7] Cen X, Liu Y, Wang S, Yang X, Shi Z, Liang X et al. Glucosamine
oral administration as an adjunct to hyaluronic acid
injection in treating temporomandibular joint osteoarthritis.
Oral Dis. 2018 Apr;24(3):404-411. doi: 10.1111/odi.12760.
- [8] Torrent A, Montell E, Vergés J, et al. SAT0547
Chondroprotective activity of acti-joint®, a combination of
chondroitin sulphate, glucosamine and a natural ıngredient
rich in hyaluronic acid. Ann Rheum Dis 2014;73(Suppl
2):789-9. doi: 10.1016/j.joca.2014.02.602
- [9] Müller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar
I. Glucosamine sulfate compared to ibuprofen in osteoarthritis
of the knee. Osteoarthritis Cartilage 1994; 2:61-9.
- [10] van der Sluijs JA, Geesink RG, van der Linden AJ, Bulstra
SK, Kuyer R, Drukker J. The reliability of the Mankin score
for osteoarthritis. J Orthop Res 1992, 10:58–61. doi:10.1002/
jor.110.010.0107
- [11] Heybeli N, Doral M N, Atay O A, Leblebicioglu G, Uzumcugil
A. Intra-articular sodium hyaluronate injections after
arthroscopic debridement for osteoarthritis of the knee: a
prospective, randomized, controlled study. Acta Orthop
Traumatol Turc 2008;42:221-7.
- [12] Şükür E, Talu C, Akman Y E, Çirci E, Öztürkmen Y, Tüzüner T.
Comparison of the chondroprotective effect of a novel hydrogel
compound and traditional hyaluronate on rat cartilage in a
papain-induced osteoarthritis model. Acta Orthop Traumatol
Turc 2016;50:458-63. doi: 10.1016/j.aott.2016.07.008
- [13] Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections
(corticosteroid, hyaluronic acid, platelet rich plasma) for
the knee osteoarthritis. World J Orthop 2014;5:351-61. doi:
10.5312/wjo.v5.i3.351
- [14] Akman Y E, Sukur E, Senel A, Sukur N E O, Talu C K,
Ozturkmen Y. The comparison of the effects of a novel
hydrogel compound and traditional hyaluronate following
micro-fracture procedure in a rat full-thickness chondral
defect model. Acta Orthop Traumatol Turc 2017;51:331-336.
doi: 10.1016/j.aott.2017.04.001.
- [15] Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects
of glucosamine sulphate on osteoarthritis progression: A
randomised, placebo-controlled clinical trial. Lancet 2001;
357:251-6.
- [16] Bannuru R R, Schmid CH, Kent DM, Vaysbrot EE, Wong J B,
McAlindon TE. Comparative effectiveness of pharmacologic
interventions for knee osteoarthritis: a systematic review and
network meta-analysis.Ann Intern Med 2015;162:46-54. doi:
10.7326/M14-1231.
- [17] Murat N, Karadam B, Ozkal S, Karatosun V, Gidener S.
Quantification of papain-induced rat osteoarthritis in relation
to time with the Mankin score. Acta Orthop Traumatol Turc
2007; 41:233-7.
- [18] Cen X, Liu Y, Wang S, Yang X, Shi Z, Liang X. Glucosamine
oral administration as an adjunct to hyaluronic acid injection
in treating temporomandibular joint osteoarthritis. Oral Dis
2018 ;24:404-411. doi: 10.1111/odi.12760. Epub 2017 Oct 4.
- [19] Jones B. Q, Covey C. J, SINEATH M. H, Sineath Jr, M. H.
Nonsurgical Management of Knee Pain in Adults. Am Fam
Physician 2015;92:875-83.
- [20] Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt
G, McGowan J at al. American College of Rheumatology
2012 recommendations for the use of nonpharmacologic and
pharmacologic therapies in osteoarthritis of the hand, hip, and
knee. Arthritis Care Res (Hoboken). 2012 ;64:465-74.
- [21] American Academy of Orthopaedic Surgeons (AAOS).
Treatment of osteoarthritis of the knee. Evidence-based
guideline. 2nd edition. AAOS 2013 May 18 PDF, summary can
be found at AAOS 2013 May 18 PDF.
- [22] McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI
guidelines for the non-surgical management of knee
osteoarthritis. Osteoarthritis Cartilage 2014;22:363-88. doi:
10.1016/j.joca.2014.01.003.
- [23] O’Hanlon CE, Newberry SJ, Booth M, et al. Hyaluronic acid
injection therapy for osteoarthritis of the knee: concordant
efficacy and conflicting serious adverse events in two
systematic reviews. Systematic reviews 2016 ;5:186.
- [24] Rutjes AW, Jüni P, da Costa BR, Trelle S, Nüesch E,
Reichenbach S. Viscosupplementation for osteoarthritis
of the knee: a systematic review and meta-analysis. Ann
Intern Med 2012;157:180-91. doi: 10.7326/0003-4819-157-3-
201208.070.00473.
- [25] Fibel KH, Hillstrom HJ, Halpern BC. State-of-the-Art
management of knee osteoarthritis. World J Clin Cases 2015
;3:89-101. doi: 10.12998/wjcc.v3.i2.89.